Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-27

Clinical Trial Update: Efficacy of Trimetazidine in Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy of trimetazidine in type 2 diabetes and diabetic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trimetazidine (trimetazidine)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies | Phase 2 | Status: UNKNOWN